Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Mariette

Showing results (61-70 of 594) with videos related to

Pageof 60
Sort By:
Best Practice & Research. Clinical Rheumatology|April 25, 2016
New biological therapies in Sjögren's syndromeGaetane Nocturne, Divi Cornec, Raphaèle Seror, et al.
The Journal of Rheumatology|May 3, 2011
Cytomegalovirus colitis and hypo-IgG after rituximab therapy for rheumatoid arthritisHélène Vallet, Ronan Houitte, Alexandre Azria, et al.
Seminars in Arthritis and Rheumatism|June 16, 2007
Perioperative management of patients with rheumatoid arthritis treated with TNF-alpha blocking agentsPhilippe Goupille, Thao Pham, Jean Sibilia, et al.
The Journal of Rheumatology|August 16, 2002
Alopecia areata in a patient with rheumatoid arthritis treated with leflunomideJacques-Eric Gottenberg, Pierre-Yves Venancie, Xavier Mariette
Joint Bone Spine|July 24, 2025
Lessons from organoid engineering for rheumatic diseaseLoïc Meudec, Negaar Goudarzi, Xavier Mariette, et al.
RMD Open|February 18, 2022
Characteristics of Sjögren's syndrome associated with rheumatoid arthritisNolan Hassold, Raphaele Seror, Xavier Mariette, et al.
Annals of the Rheumatic Diseases|September 11, 2019
New 2019 SLE EULAR/ACR classification criteria are valuable for distinguishing patients with SLE from patients with pSSFlorence Assan, Raphaele Seror, Xavier Mariette, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 15, 2017
Cost-Effectiveness of TNF-Blocker Injection Spacing for Patients with Established Rheumatoid Arthritis in Remission: An Economic Evaluation from the Spacing of TNF-Blocker Injections in Rheumatoid Arthritis TrialAntoine Vanier, Xavier Mariette, Florence Tubach, et al.
Rheumatic Diseases Clinics of North America|July 20, 2016
Use of Biologics in Sjögren's SyndromeGaetane Nocturne, Divi Cornec, Raphaèle Seror, et al.
The Journal of Rheumatology|August 3, 2015
Orbital Myositis and Primary Sjögren SyndromeFrançois-Xavier Danlos, Fadela Daoued, Raphaèle Seror, et al.
Pageof 60

Showing results (61-70 of 594) with videos related to

Sort By:
Pageof 60
Best Practice & Research. Clinical Rheumatology|April 25, 2016
New biological therapies in Sjögren's syndromeGaetane Nocturne, Divi Cornec, Raphaèle Seror, et al.
The Journal of Rheumatology|May 3, 2011
Cytomegalovirus colitis and hypo-IgG after rituximab therapy for rheumatoid arthritisHélène Vallet, Ronan Houitte, Alexandre Azria, et al.
Seminars in Arthritis and Rheumatism|June 16, 2007
Perioperative management of patients with rheumatoid arthritis treated with TNF-alpha blocking agentsPhilippe Goupille, Thao Pham, Jean Sibilia, et al.
The Journal of Rheumatology|August 16, 2002
Alopecia areata in a patient with rheumatoid arthritis treated with leflunomideJacques-Eric Gottenberg, Pierre-Yves Venancie, Xavier Mariette
Joint Bone Spine|July 24, 2025
Lessons from organoid engineering for rheumatic diseaseLoïc Meudec, Negaar Goudarzi, Xavier Mariette, et al.
RMD Open|February 18, 2022
Characteristics of Sjögren's syndrome associated with rheumatoid arthritisNolan Hassold, Raphaele Seror, Xavier Mariette, et al.
Annals of the Rheumatic Diseases|September 11, 2019
New 2019 SLE EULAR/ACR classification criteria are valuable for distinguishing patients with SLE from patients with pSSFlorence Assan, Raphaele Seror, Xavier Mariette, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 15, 2017
Cost-Effectiveness of TNF-Blocker Injection Spacing for Patients with Established Rheumatoid Arthritis in Remission: An Economic Evaluation from the Spacing of TNF-Blocker Injections in Rheumatoid Arthritis TrialAntoine Vanier, Xavier Mariette, Florence Tubach, et al.
Rheumatic Diseases Clinics of North America|July 20, 2016
Use of Biologics in Sjögren's SyndromeGaetane Nocturne, Divi Cornec, Raphaèle Seror, et al.
The Journal of Rheumatology|August 3, 2015
Orbital Myositis and Primary Sjögren SyndromeFrançois-Xavier Danlos, Fadela Daoued, Raphaèle Seror, et al.
Pageof 60